Evidence map›Paper›PMID 29533925›Full record

ArticleThe Journal of clinical investigation2018

Circadian clock component REV-ERBα controls homeostatic regulation of pulmonary inflammation.

Marie Pariollaud, Julie E Gibbs, Thomas W Hopwood, Sheila Brown, Nicola Begley, Ryan Vonslow, Toryn Poolman, Baoqiang Guo, Ben Saer, D Heulyn Jones and 16 more

Open access · hybridAbstract readVideo-Audio Media
In one paragraph

Article in The Journal of clinical investigation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 130 papers.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

130 citing papers in PubMed, 198 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. REV-ERB-alpha and -beta coordinately regulate astrocyte reactivity and proteostatic function.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. The βScience advances · 2025
    Article
  19. Article
  20. Review

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 6 institutions in 3 countries.

Marie PariollaudFaculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Julie E GibbsFaculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Thomas W HopwoodFaculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Sheila BrownFaculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Nicola BegleyFaculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Ryan VonslowFaculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Toryn PoolmanFaculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Baoqiang GuoFaculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Ben SaerFaculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
D Heulyn JonesDepartment of Pure and Applied Chemistry, University of Strathclyde, Glasgow, United Kingdom.
James P TellamDepartment of Pure and Applied Chemistry, University of Strathclyde, Glasgow, United Kingdom.
Stefano BrescianiDepartment of Pure and Applied Chemistry, University of Strathclyde, Glasgow, United Kingdom.
Nicholas Co TomkinsonDepartment of Pure and Applied Chemistry, University of Strathclyde, Glasgow, United Kingdom.
Justyna Wojno-PiconDepartment of Pure and Applied Chemistry, University of Strathclyde, Glasgow, United Kingdom.
Anthony Wj CooperDepartment of Pure and Applied Chemistry, University of Strathclyde, Glasgow, United Kingdom.
Dion A DanielsGlaxoSmithKline R&D, Stevenage, United Kingdom.
Ryan P TrumpMolecular Discovery Research, GlaxoSmithKline, Research Triangle Park, North Carolina, USA.
Daniel GrantMolecular Discovery Research, GlaxoSmithKline, Research Triangle Park, North Carolina, USA.
William ZuercherMolecular Discovery Research, GlaxoSmithKline, Research Triangle Park, North Carolina, USA.
Timothy M WillsonMolecular Discovery Research, GlaxoSmithKline, Research Triangle Park, North Carolina, USA.
Andrew S MacDonaldFaculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Brian BologneseStress and Repair Discovery Performance Unit, Respiratory Therapy Area, GlaxoSmithKline, King of Prussia, Pennsylvania, USA.
Patricia L PodolinStress and Repair Discovery Performance Unit, Respiratory Therapy Area, GlaxoSmithKline, King of Prussia, Pennsylvania, USA.
Yolanda SanchezStress and Repair Discovery Performance Unit, Respiratory Therapy Area, GlaxoSmithKline, King of Prussia, Pennsylvania, USA.
Andrew Si LoudonFaculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
David W RayFaculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
University of Manchester · GBUniversity of Strathclyde · GBGlaxoSmithKline (United Kingdom) · GBUniversity of North Carolina at Chapel Hill · USNovartis (Switzerland) · CHResearch Triangle Park Foundation · US

Funding

Biotechnology and Biological Sciences Research Council BB/L000954/1Medical Research Council MR/M008908/1Medical Research Council MR/P011853/1Medical Research Council MR/P011853/2Medical Research Council MR/P023576/1Versus Arthritis 20629Wellcome Trust 107851/Z/15/Z
6 · The paper itself

Abstract

Recent studies reveal that airway epithelial cells are critical pulmonary circadian pacemaker cells, mediating rhythmic inflammatory responses. Using mouse models, we now identify the rhythmic circadian repressor REV-ERBα as essential to the mechanism coupling the pulmonary clock to innate immunity, involving both myeloid and bronchial epithelial cells in temporal gating and determining amplitude of response to inhaled endotoxin. Dual mutation of REV-ERBα and its paralog REV-ERBβ in bronchial epithelia further augmented inflammatory responses and chemokine activation, but also initiated a basal inflammatory state, revealing a critical homeostatic role for REV-ERB proteins in the suppression of the endogenous proinflammatory mechanism in unchallenged cells. However, REV-ERBα plays the dominant role, as deletion of REV-ERBβ alone had no impact on inflammatory responses. In turn, inflammatory challenges cause striking changes in stability and degradation of REV-ERBα protein, driven by SUMOylation and ubiquitination. We developed a novel selective oxazole-based inverse agonist of REV-ERB, which protects REV-ERBα protein from degradation, and used this to reveal how proinflammatory cytokines trigger rapid degradation of REV-ERBα in the elaboration of an inflammatory response. Thus, dynamic changes in stability of REV-ERBα protein couple the core clock to innate immunity.

Indexed as

Immunity, InnateAnimalsCircadian ClocksCircadian RhythmHomeostasisMiceMice, TransgenicNuclear Receptor Subfamily 1, Group D, Member 1PneumoniaProteolysisSumoylationNr1d1 protein, mouseNuclear Receptor Subfamily 1, Group D, Member 1InflammationInnate immunityMouse modelsNeutrophilsPulmonology

Identifiers

PMID29533925
PMCPMC5983347
OpenAlexW2793930217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.